Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.
Molecular Oncology|April 10, 2013
Are two better than one? A novel double-mutant KIT in GIST that responds to ImatinibElena Conca, Claudia Miranda, Valentina Dal Col, et al.
Endocrine-Related Cancer|November 8, 2012
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cellsDebora Degl'Innocenti, Paola Romeo, Eva Tarantino, et al.
Cancer Letters|February 17, 2020
COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell deathTiziana Di Marco, Francesca Bianchi, Lucia Sfondrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2010
Functional mapping of receptor tyrosine kinases in myxoid liposarcomaTiziana Negri, Emanuela Virdis, Silvia Brich, et al.
Cancer Letters|November 17, 2018
Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cellsElena Cetti, Tiziana Di Marco, Giuseppe Mauro, et al.
Endocrine-Related Cancer|June 22, 2011
Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphismMaria Grazia Borrello, Antonella Aiello, Bernard Peissel, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 3, 2025
Innovations in randomized clinical trials in Nephrology: from study design to patient's activismGiuseppe Pezzi, Roberta Arena, Giuliana Papalia, et al.
Frontiers in Endocrinology|October 23, 2023
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumorsEmanuela Minna, Andrea Devecchi, Federico Pistore, et al.
Cancer Letters|September 28, 2017
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cellsMaria Chiara Anania, Elena Cetti, Daniele Lecis, et al.
Pageof 8